Navigation Links
Women Injured by Bestselling Diabetes Drug Lipitor Take on Pfizer in St. Louis Circuit Court
Date:9/26/2013

ST. LOUIS, Sept. 26, 2016 /PRNewswire/ -- The Simmons Law Firm filed suit Aug. 26 against Pfizer, Inc., on behalf of 71 women with healthy Body Mass Indexes alleging they developed type 2 diabetes as a result of taking Lipitor, a cholesterol-lowering drug manufactured by the pharmaceutical giant. The suit (Case No. 1322-CC09218) was filed in the 22nd Circuit Court of Missouri in the City of St. Louis after the application to consolidate the cases into a Federal Multidistrict Litigation was denied.

(Logo: http://photos.prnewswire.com/prnh/20130926/CL85566LOGO)

"We are looking forward to helping these and other women across the country have their day in court," said Shareholder and Pharmaceutical Department Head Trent Miracle. Simmons is a national litigation firm known for handling dangerous drug and device cases.

Lipitor, a statin, entered the market in the mid-1990s. It was designed to regulate the amount of cholesterol in the blood. Pfizer has spent hundreds of millions of dollars on marketing and advertising the drug.

The complaint alleges Pfizer did not conduct adequate studies or issue any warnings even though their internal data showed Lipitor placed women at an elevated risk of developing type 2 diabetes.

The Lipitor attorneys at the Simmons Firm are currently investigating claims from women diagnosed with type 2 diabetes after taking Lipitor.

About Simmons Browder Gianaris Angelides & Barnerd LLC
The Simmons Firm is a leading law firm in dangerous drug and medical device litigation. The Simmons Firm has experience in litigating complex medical matters and has taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs. The firm has recovered hundreds of millions of dollars for its pharmaceutical clients in cases involving Oxycontin, Yaz, Bextra and more. Learn more at www.simmonspharmalaw.com.


'/>"/>
SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 15 October 2013 Breast Health Day: From Spain to Tajikistan, from Israel to Sweden, a Day Dedicated to the Breast Health of Women Worldwide
2. Many Women Not Warned About Mesh Implant Risks
3. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
4. New Data Suggests Abbotts High Sensitive Troponin Test May Help Doctors More Accurately Diagnose Heart Attacks in Women
5. Pharmaceutical Patent Sale of First-in-Class Compounds to Treat Womens Health Needs
6. The Foundation for Womens Cancer to Host 6th Annual Race for Awareness at Arlington Park
7. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
8. S1 Biopharma Doses First Patients in Phase 2a Clinical Trial of Lorexys in Premenopausal Women with HSDD
9. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
10. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the AT&T National
11. New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... Israel , May 30, 2017 DarioHealth Corp. (NASDAQ: ... big data solutions, today announced that it will be presenting at ... at 8:00 AM PT. Erez Raphael , CEO, of DarioHealth ... The conference will be held on June 6th & 7th, 2017 ... companies in the small / micro-cap space. ...
(Date:5/29/2017)... 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... enables the functional selection of stem cells, today provided ... first quarter ended March 31 st , 2017. ... in the first quarter of 2017," said Dr. Shai ... announced the treatment of the first blood cancer patient ...
Breaking Medicine Technology:
(Date:6/26/2017)... ... ... KICKICO , a protocol built on Ethereum for more transparent ICO and ... funding campaigns. KICKICO developers are testing the platform, which will launch for the public ... through the power of many - has been around for about ten years as ...
(Date:6/25/2017)... ... ... a feel-good lyric music video in Final Cut Pro X with ProLyric from Pixel Film ... the lyrics to any song. ProLyric flies in the text for each section and it ... added modularly for optimal control. ProLyric makes editing any music video or text-based production easier ...
(Date:6/25/2017)... ... 25, 2017 , ... CareSet Labs released the Root NPI Graph today at ... new, greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. ... subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as ...
(Date:6/24/2017)... ... 24, 2017 , ... Genes Advice, a new company based ... and Texas doctors' offices and clinics. This breakthrough testing is part of the ... the role genes play in determining an individual's tolerance of and reaction to ...
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating up ... Home and business owners should be aware that the summer months provide more than ... mechanical locks and keys can be negatively affected from direct exposure to the sun. ...
Breaking Medicine News(10 mins):